THE WIRE · № 82774
Antiviral Drugs Market to Reach USD 125.26 Billion by 2035
01 THE MACHINE READ
WHY IT MATTERS.
A paid market-research forecast for antiviral drugs is a vendor projection, not a traded catalyst; it signals only long-run demand framing.
Sponsored market-sizing report, no actionable equity signal
Actual antiviral sales data from drugmakers
Forecasts are vendor-produced and unverified
FULL DISPATCH
LONDON, Oct. 15, 2026 /PRNewswire/ -- The "Antiviral Drugs Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035" report has been added to the Credence Research Inc. market intelligence offering. The global antiviral drugs market was valued at USD 77.93 billion in 2025...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
HOPE CHARITIES RECEIVES FAVORABLE OIG ADVISORY OPINION TO EXPAND PATIENT ASSISTANCE PROGRAM FOR FEDERAL HEALTHCARE BENEFICIARIES2026-10-15 18:24 UTC
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets2026-10-15 18:25 UTC
Tucuvi joins the Microsoft Pegasus Program to scale clinically governed AI Care Management across health systems2026-10-15 18:40 UTC
New England Biolabs® and seqWell Announce Strategic Partnership and Commercial Launch of High-Performance TnX® Transposase (Unloaded)2026-10-15 19:00 UTC
Kohler Health Marks One-Year Anniversary of Dekoda with Acclaimed Industry Recognition for Innovation and Design2026-10-15 19:25 UTC
Hungry for Scale, Wary of Reimbursement: The Behavioral Health M&A Dilemma2026-10-15 19:56 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.